Figure 2.

Markov model showing possible outcomes incorporated in the cost-effectiveness analysis of targeted HTLV-1 antenatal screening in England and Wales

ATL: adult T-cell leukaemia; HAM: HTLV-1-associated myelopathy; HTLV-1: Human T-cell lymphotropic virus type 1.

This figure was adapted from Rosadas et al. [18].